Filing Details

Accession Number:
0001274644-17-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-28 16:06:35
Reporting Period:
2017-03-28
Filing Date:
2017-03-28
Accepted Time:
2017-03-28 16:06:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274644 Ocera Therapeutics Inc. OCRX Pharmaceutical Preparations (2834) 631192270
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619893 Michael Byrnes C/O Ocera Therapeutics, Inc.
525 University Avenue, Suite 610
Palo Alto CA 94301
Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-28 3,000 $1.28 13,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct